SecBot SecBot
SC 13G/A ·Filed Nov 12, 2026

KPTI

Karyopharm Therapeutics Inc.
NEUTRAL
Impact 3/10
Horizonweeks Processed4d 18h ago SEC0000919574-26-007570
Passive stake amendment
Actionable Insight • Neutral

Monitor for any future conversion to a 13D filing or additional stake increases, which could signal a shift from passive to activist intent. The large increase in a micro-cap stock warrants attention.

DirectionNeutral
Confidencehigh
Horizonweeks

How the stock moved after the report

NEUTRAL VIEWSTOCK BELOW ENTRY AT T+1
Entry
$0.0260
T+0 close · Nov 12, 2026 · via day close
Latest settled
−3.85%
T+1 · $0.0250 · next T+5 in 2d
Vs SPY
−3.48%
α at T+1
Latest observation
+9.94%
T+2 · FF3 residual α
  1. T+0 · Nov 12 $0.0260entry
  2. T+1 · 4d ago −3.85%α −3.48% · $0.0250
  3. T+2 · todayOpen
  4. T+5 · in 2d Pending
  5. T+20 · in 24d Pending
  6. T+60 · in 3mo Pending

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Adage Capital Management filed an amended Schedule 13G disclosing a beneficial ownership of 2,013,106 shares (8.87%) of Karyopharm Therapeutics as of September 30, 2026, up from 203,129 shares (0.9%) in the prior filing three days ago. This is a large increase in a passive stake, but given the company's tiny $1M market cap and the passive nature of the filing, the impact is neutral.

Key Financial Metrics

Stake
8.87%
Investor
Adage Capital Management, L.P.
Investor Type
hedge fund

Key Facts

  • Adage Capital Management disclosed beneficial ownership of 2,013,106 shares (8.87%) of Karyopharm Therapeutics as of September 30, 2026.
  • This is an increase from 203,129 shares (0.9%) disclosed in the prior SC 13G/A filed November 9, 2026.
  • The stake includes 15,414 shares issuable upon exercise of warrants.
  • The percentage is based on 22,681,460 shares outstanding as of August 6, 2026.
  • The filing is a passive investor update under Rule 13d-1(b); no activist intent is indicated.

Financial Impact

Stake increased by approximately 1,809,977 shares; value at snapshot market cap of $1M is approximately $88,500.

ownership percentage

Risk Factors

  • Passive filing; no activist intent stated, but a large stake increase could precede future engagement.
  • Company has a very small market cap ($1M), making it highly volatile and susceptible to ownership changes.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
82% bullish (11 analysts)

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
SC 13G/A Filing (Primary)0000919574-26-007570
Document: 0000919574-26-007570-index.html0000919574-26-007570
Document: 0000919574-26-007570.txt0000919574-26-007570

Track record

30 reports on KPTI

Performance horizon

5 of 5 bullish or bearish reports moved the stock their way by T+60. Best: +97.24% at T+60 after the Aug 13, 2026 report. 13 of 14 went positive at some point.

Filters
  1. Nov 13, 20263d ago SC 13G/A Neutral 3/10 Entry $0.0102 Now $0.0290 +184.31% settles Feb 12
  2. Nov 13, 20263d ago NT 10-Q Bearish 7/10 Entry $0.0102 Now $0.0290 −184.31% settles Feb 12
  3. Nov 12, 20264d ago SC 13G/A Neutral 3/10 Viewing Entry $0.0260 Now $0.0290 +11.54% settles Feb 10
  4. Nov 9, 20267d ago SC 13G/A Neutral 2/10 Entry $0.0400 Now $0.0290 −27.50% settles Feb 5
  5. Nov 5, 202611d ago 8-K Bearish 8/10 Entry $0.0601 Now $0.0290 +51.75% settles Feb 3
  6. Nov 2, 202614d ago 8-K Bearish 10/10 Entry $0.0883 Now $0.0290 +67.16% settles Feb 1
  7. Nov 2, 202614d ago 8-K Bearish 7/10 Entry $0.1120 Now $0.0290 +74.11% settles Jan 29
  8. Oct 28, 202619d ago SC 13G/A Bearish 5/10 Entry $0.8798 Now $0.0290 +96.70% settles Jan 27
  9. Oct 22, 202625d ago 8-K Bearish 6/10 Entry $0.5175 Now $0.0290 +94.40% settles Jan 21
  10. Oct 14, 20264w ago 8-K Neutral 3/10 Entry $0.3150 Now $0.0290 −90.79% settles Jan 11
Showing 10 of 30

US Market Status

Market Closed · Opens in 5h 41m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 12, 2026